Biography:

Joshua Ko's research focuses on the signalling pathways of anti-carcinogenic agents, with special interest in the pharmacological actions of herbal terpenoids and flavonoids when treating gastrointestinal cancers, particular that of the colon, pancreas and the liver, as well as to identify the key molecular drug targets. Current new ventures include the use of microRNA technology and tumor-targeting peptide, and to study modulation of the autophagy mechanism as well as the tumor microenvironment. He also performs works related to gastroprotection and colitis diseases.